<DOC>
	<DOCNO>NCT01493622</DOCNO>
	<brief_summary>The purpose study determine whether minocycline effective treatment negative cognitive symptom schizophrenia .</brief_summary>
	<brief_title>The Study Minocycline Negative Cognitive Symptoms Schizophrenia</brief_title>
	<detailed_description>Immune-related disorder hypothesize etiological factor schizophrenia.Minocycline second-generation tetracycline exert anti-inflammatory antimicrobial effect distinct neuroprotective profile.This study perform double-blind , placebocontrolled , randomized evaluation Second generation antipsychotic ( SGA ) minocycline versus SGA placebo .</detailed_description>
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Neurobehavioral Manifestations</mesh_term>
	<mesh_term>Minocycline</mesh_term>
	<criteria>male female , age 1840 year currently diagnose DSMIV schizophrenia able comprehend cognition test patient guardian sign informed consent , able comprehend procedure aim study , agree join study patient 's current antipsychotic medication regimen must stable must stable living arrangement ever hypersensitivity minocycline tetracycline ; acute , unstable , significant , untreated medical illness besides schizophrenia pregnant breastfeeding ; DSMIV diagnosis substance abuse dependency ; tendency suicide Violence , selfharm ; take immunosuppressive agent precede 3 month study entry ; influenza fever precede 2 week study entry ; DSMIV diagnosis emotional psychosis , Mental retardation , etc . suicidal attempts ideation violent behavior within last 12 month patient mental retardation severe organic brain syndrome treatment Electroconvulsive Therapy ( ECT ) within 6 month prior screen</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>December 2011</verification_date>
	<keyword>Schizophrenia minocycline cognition</keyword>
</DOC>